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Abstract
Background: The need to develop supplementary or alternative treatments for seasonal affective disorder (SAD) is
underscored by the significant minority (47%) of SAD patients that is refractory to light therapy, the persistence of residual
symptoms despite light treatment, and poor long-term compliance with light use. Because preliminary studies suggest that
cognitive and behavioral factors are involved in SAD, cognitive-behavioral therapy (CBT) warrants investigation as a possible
treatment option. Methods: We piloted a 6-week randomized clinical trial to compare a standard light therapy protocol; a novel,
SAD-tailored, group CBT intervention; and their combination in ameliorating and remitting a current SAD episode and as
prophylaxis against episode recurrence. Depressive symptom severity and remission rates were assessed at post-treatment and at
a 1-year follow-up visit to examine long-term treatment durability. Results: CBT, light therapy, and their combination all
demonstrated significant reductions in depressive symptoms on two different outcome measures. Remission rates varied by
measure, but did not reach statistical significance. During the subsequent winter, CBT, particularly in combination with light
therapy, appeared to improve long-term outcome regarding symptom severity, remission rates, and relapse rates. No CBT-
treated participant, with or without light, experienced a full SAD relapse compared to over 60% of those treated with light
alone. Limitations: These results should be viewed as preliminary and are limited by the small sample size (n=23) and lack of a
control group. Conclusions: The nearly half of SAD patients who do not remit with light alone may benefit from CBT as an
adjunct or alternative treatment, especially as a prophylaxis against episode recurrence.
Published by Elsevier B.V.
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1. Introduction
Seasonal affective disorder (SAD) is a recurrent
fall–winter depression with periods of remission in
spring and summer (Rosenthal et al., 1984). Light
therapy, involving daily exposure to bright light
during the symptomatic months, is the current ‘gold
standard’ for SAD treatment. A pooled analysis
concluded that 53.3% of individuals with SAD
overall, and only 43% of those with moderate to
severe SAD demonstrated clinically significant im-
provement in depressive symptoms with light treat-
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ment (Terman et al., 1989). Therefore, a significant
minority of SAD individuals does not remit with
light therapy, especially those with more severe
symptoms and those who experience more typical
depressive features (Terman et al., 1996). Moreover,
a recent study contrasting the degree of improvement
with light therapy with spontaneous remission status
in the summer revealed residual symptoms with light
treatment (Postolache et al., 1998). Light therapy
requires a considerable daily time commitment from
the patient during the symptomatic months, contrib-
uting to a 59% discontinuation rate after the research
protocol (Schwartz et al., 1996). For all of these
reasons, the development of supplementary and/or
alternative treatments is warranted.
Extensive literature documents the efficacy of
cognitive-behavioral therapy (CBT; Beck et al.,
1979) for nonseasonal major depression (e.g. DeRu-
beis et al., 1999; Dobson, 1989; Gloaguen et al., 1998;
USDHHS, 1993). Although SAD, like major depres-
sive disorder, has important biological underpinnings
(e.g. Wehr et al., 2001), preliminary studies suggest
that cognitive and behavioral factors may be involved
in SAD, including automatic thoughts, dysfunctional
attitudes, behavioral withdrawal, low rates of positive
reinforcement, and rumination (Azam and Young,
1998; Hodges and Marks, 1998; Rohan et al., 2003).
Therefore, CBT, which effectively targets these cog-
nitions and behaviors, may be an appropriate addi-
tional treatment option for SAD. One small study
found that group cognitive or group behavioral ther-
apy significantly improved SAD symptoms relative to
a wait list-control (Sigmon et al., 2000). However, the
efficacy of a full CBT package (i.e. restructuring
cognitions and behavioral activation), the comparative
efficacy of CBT and light therapy, and the potentially
additive benefits of combining CBT and light remain
unknown.
Importantly, the benefits of CBT appear to extend
beyond the point of termination. Patients treated with
CBT demonstrate a reduced risk for major depressive
episode relapse relative to pharmacotherapy or clinical
management (Blackburn et al., 1986; Fava et al.,
1998; Paykel et al., 1999). This treatment ‘durability’
has been attributed to active use of skills learned in
CBT to alleviate residual and subsequent depressive
symptoms, although studies have not directly tested
this assumption. Given that SAD has a predictable
winter depressive episode recurrence and spring re-
mission (Graw et al., 1997; Leonhardt et al., 1994;
Sakamoto et al., 1995), treatments that function as
prophylaxis against subsequent episodes would be
highly beneficial. To date, the only preventive re-
search for SAD has implemented light therapy in the
autumn prior to relapse (e.g. Meesters et al., 1994;
Partonen and Lo¨nnqvist, 1996).
The purpose of this study was to provide
preliminary data on a novel, SAD-tailored cogni-
tive-behavioral approach to treating SAD. To this
end, we conducted a 6-week randomized pilot
study comparing two single treatment modalities
(i.e. light therapy and CBT) and their combined
‘synergistic’ effects in ameliorating and remitting a
current SAD episode. We also examined the com-
parative durability of these treatments at a 1-year
follow-up (i.e. during the subsequent winter). We
hypothesized that CBT would be comparable in
efficacy to light therapy and that their combination
would confer additive benefits in both the short-
and long-term.
Because the application of CBT to SAD has not
been previously tested, we consider this line of study
to be in the early pilot/feasibility testing stage
necessary for developing new treatments (see Roun-
saville and Carroll, 2001). To minimize risks to
participants and to alleviate ethical problems inherent
to this preliminary phase of investigation, standard of
care or best available treatment controls are often
selected over wait-list or no-treatment control groups
(Kendall et al., 1999). Thus, we elected to use the
best available treatment (i.e. light therapy) as the
basis for comparing our new CBT intervention to
determine whether more sophisticated, controlled




Adult community residents in the greater Wash-
ington, DC, metropolitan area (39j North) were
recruited for this study via advertisements during
fall 2000. Inclusion criteria for the study were: (a)
DSM-IV criteria for major depression, recurrent,
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with seasonal pattern on the Structured Clinical
Interview for DSM-IV Axis I Disorders–Clinician
Version (SCID-CV; First et al., 1995), and (b) a
current winter SAD episode as assessed by the
Structured Interview Guide for the Hamilton Rating
Scale for Depression–Seasonal Affective Disorder
Version (SIGH-SAD; Williams et al., 1992; see
description of SIGH-SAD scoring criteria below).
Exclusion criteria included: (a) current psychological
or psychiatric treatment (i.e. psychotropic medica-
tions, psychotherapy, light therapy) or immediate
plans to initiate such treatment, (b) presence of any
other current Axis I disorder, (c) plans for major
vacations or absences through March, and (d) bipo-
lar-type SAD. Acknowledging the pilot nature of this
study, we loosened our exclusionary criteria follow-
ing initial recruitment efforts in order to increase
sample size. We included a small sample that other-
wise satisfied all study criteria, but was taking stable
doses of antidepressant medications.
2.2. Measures
2.2.1. Structured Interview Guide for the Hamilton
Rating Scale for Depression–Seasonal Affective
Disorder version (SIGH-SAD)
The SIGH-SAD (Williams et al., 1992) is the
most commonly used clinical assessment device for
detecting changes in SAD symptom severity. It
includes the 21-item Structured Interview Guide for
the Hamilton Rating Scale for Depression (HAM-D)
and a supplementary SAD subscale comprised of
eight questions that assess atypical depressive fea-
tures common in SAD such as hypersomnia and
carbohydrate craving. Two trained raters, blind to
treatment group assignment, administered the SIGH-
SAD and obtained high inter-rater reliability (rs=0.93
at pre-treatment; 0.99 at post-treatment, and 0.99 at
1-year).
Based on accepted guidelines (Terman et al.,
1990), the following criteria were used to define
SAD episode onset and relapse: total SIGH-SAD
score z 20 +HAM-D score z 10 + atypical score
z 5. The two possible ways to classify remission are
(Terman et al., 1990): (1) pre- to post-treatment
reduction in total SIGH-SAD score z 50%+HAM-
D score V 7+ atypical score V 7, or (2) HAM-D score
V 2+ atypical score V10.
2.2.2. Beck Depression Inventory–Second Edition
(BDI-II)
The BDI-II (Beck et al., 1996) is a widely used
21-item self-report measure of depressive symptom
severity with high test–retest reliability and conver-
gent validity (Beck et al., 1996). The BDI has been
used to estimate remission rates subsequent to treat-
ment (e.g. Gortner et al., 1998). Consistent with this
approach, remission was defined as a BDI-II score
V8.
2.2.3. Pre-treatment survey
At pre-treatment, participants were given a brief
survey to assess their expectations for the study.
Specifically, participants were asked (1) to rank-order
the three treatments under study in expected efficacy
from 1 (‘most effective’) to 3 (‘least effective’), (2) to
rate the expected efficacy of the treatments on a 1
(‘not at all effective’) to 10 (‘very effective’) scale,
and (3) to rank-order the treatments in order of
personal preference from 1 (‘most preferred’) to 3
(‘least preferred’) treatment option.
2.2.4. 1-Year follow-up survey
At the 1-year follow-up visit, participants were
surveyed about their SAD-management behaviors
over the past year. Items assessing cognitive and
behavioral strategies included: ‘thinking positively’,
‘increasing my activity level (doing things I enjoy)’,
‘socializing with other people’, ‘being more aware of
my SAD symptoms’, and ‘exercising’. Strategies
consistent with a light therapy approach included:
‘using a light box’, ‘going outside’, ‘making my home
brighter’, ‘going South on a trip/vacation’, and ‘keep-
ing a regular sleep schedule’. Participants rated items
on frequency (0 ‘almost never’, 1 ‘sometimes’, 2
‘often’, 3 ‘almost always’) and helpfulness (0 ‘com-
pletely unhelpful’, 1 ‘slightly helpful’, 2 ‘moderately
helpful’, 3 ‘very helpful’). The survey also asked yes/
no questions about ongoing use of light therapy,
participation in psychotherapy, and use of antidepres-
sant medications.
2.3. Treatment protocols
2.3.1. Cognitive-behavioral therapy (CBT)
CBT was conducted in group format for 1.5-h ses-
sions twice a week over 6 weeks (total of 12 sessions)
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with four to six participants per group. Although CBT
is typically administered for 12–20 sessions (Ilardi
and Craighead, 1994), SAD necessitates an intensified
version because SAD patients may spontaneously
remit with the arrival of spring if CBTwere conducted
weekly over 20 weeks.
We tailored traditional CBT to address the spe-
cial needs of the SAD population in developing and
manualizing our ‘Coping with the Seasons’ proto-
col. The protocol addressed the role of environmen-
tal changes as well as cognitions and behavior in
symptom onset and maintenance. Through the tra-
ditional CBT elements of behavioral activation and
cognitive restructuring, our CBT focused on im-
proved coping with the winter season. Some cog-
nitive restructuring focused on challenging negative
thoughts related to the winter season, weather con-
ditions, and lack of light. A relapse-prevention
component addressed early identification of negative
anticipatory thoughts about winter and SAD-related
behavior changes, how to use the skills learned to
cope with subsequent winter seasons, and develop-
ment of a personalized relapse-prevention plan. The
first author, a licensed psychologist, served as the
primary therapist with a clinical psychology practi-
cum student as co-therapist.
2.3.2. Light therapy (LT)
LT was administered according to the NIMH
Biological Rhythms Section’s standard treatment
protocol (Holly Low, personal communication). Spe-
cifically, LT participants used the 10,000 lux stan-
dard light box in their homes in 45-min doses,
twice daily: once between 06:00 and 09:00 h and
again between 18:00 and 21:00 h. Participants
recorded their light use with diary forms. Although
therapeutic response typically occurs within 2 weeks
of initiating light therapy (Labbate et al., 1995), the
LT protocol in this study was maintained and
monitored for 6 weeks to match the duration of
the CBT.
2.3.3. Cognitive behavioral therapy and light therapy
(CBT+LT)
CBT+LT participants received all elements of both
the LT and CBT protocols (i.e. daily light exposure
and twice-weekly group CBT simultaneously for 6
weeks).
2.4. Screening procedures
We reviewed 265 phone responses to media adver-
tisements. Of these, 164 were contacted and agreed to
undergo a phone screen to assess the exclusion criteria
and history of SAD. Those who did not meet the study
criteria and/or did not want to volunteer received a
mental health referral list. The 43 individuals who
satisfied phone screening criteria and expressed inter-
est in volunteering were invited to the laboratory to
review the informed consent document. All but one
individual consented to the study procedures and was
subsequently interviewed using the Structured Clini-
cal Interview for DSM-IV Axis I Disorders (SCID-
CV; First et al., 1995). Individuals who met DSM-IV
criteria for major depression, recurrent, with seasonal
pattern (n=28) were interviewed with bi-weekly
SIGH-SADs to monitor for onset of a current SAD
episode. This strategy was necessary because individ-
uals differ in the timing of episode onset. Individuals
who went on to meet SIGH-SAD criteria for a current
SAD episode (n=26) were then actively enrolled in
the study.
2.5. Study procedures
After meeting SIGH-SAD criteria for a current
SAD episode, participants completed the BDI-II and
pre-treatment expectations survey and were subse-
quently randomized to a treatment group. Treatment
protocols were initiated between the first week of
December 2000 and the fourth week of January 2001
and completed between the second week of January
and the first week of March 2001. Following the 6-
week treatment phase, the SIGH-SAD and BDI-II
were re-administered.
Participants who completed the trial were invited to
attend a follow-up visit during the winter subsequent
to treatment completion. Those who agreed to return
reviewed and signed an informed consent document
and completed the SIGH-SAD, BDI-II, and 1-year
follow-up survey. The follow-ups occurred between
the second week of January and the fourth week of
March 2002. Participants were paid $20 for attending
the pre-treatment visit, $40 for the post-treatment
assessment, and $50 for the 1-year follow-up. The
Institutional Review Board at the Uniformed Services
University approved this study.
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2.6. Data analytic strategy
Consistent with prior SAD treatment research (Ter-
man et al., 1990), two analytic approaches were used.
The first (i.e. low threshold) approach involves ex-
amining statistically significant differences in pre- to
post-treatment symptom severity scores. To this end, a
3 (treatment group: CBT, LT, CBT+LT)2 (measure-
ment occasion: pre-treatment, post-treatment) repeat-
ed measures analysis of variance (ANOVA) was
conducted on SIGH-SAD and BDI-II scores. The
second (i.e. high threshold) method uses a chi-square
analysis to compare the proportion of participants
achieving complete symptom remission on the
SIGH-SAD and BDI-II. Similar analyses were con-
ducted on the 1-year follow-up data.
3. Results
3.1. Post-treatment results
3.1.1. Participant characteristics and attrition
Two participants, both randomized to the CBT
group, dropped out of the study immediately upon
group assignment. One other participant in the
CBT+LT group was lost to follow-up during treat-
ment. The final sample of 23 completers (seven CBT,
nine LT, seven CBT+LT) was predominantly female
(91.3%), Caucas ian (87.0%), middle-aged
(mean=50.5 years; S.D.=12.6), married (66.7%), col-
lege-educated (72.2%), and currently employed
(69.6%). Three were taking stable doses of antide-
pressant medication, assigned one to each treatment
group. The three treatment groups did not significant-
ly differ on depression severity before treatment
initiation on either the SIGH-SAD or BDI-II (see
Figs. 1 and 2).
3.1.2. Participant expectancies and preferences
On the pre-treatment survey, participant expect-
ations regarding treatment effectiveness and preferen-
ces were revealed. The majority of participants
(69.6%) expected CBT+LT to be the most effective
treatment option followed by LT (26.1%) and CBT
(4.3%). A greater proportion of participants rated
CBT+LT as the most effective treatment than as
second or third in effectiveness, v2(2, N=23)=13.65,
P=0.001. Similarly, on Likert ratings of effectiveness,
participants anticipated CBT + LT (mean=8.86,
S.D.=0.77) to be more effective than LT (mean=7.18,
S.D.=1.30), t(21)=5.53, or CBT (mean=5.57,
Fig. 1. SIGH-SAD scores across occasions.
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S.D.=1.59), t(22)=9.64, both Ps<0.001. In addition,
LT was rated as more effective than CBT, t(22)=3.81,
P<0.001. The majority of participants ranked
CBT+LT (56.5%) as their most preferred treatment
option followed by LT (43.5%) and CBT (4.3%).
Again, CBT+LT was ranked more frequently as the
most desirable intervention than as second or third in
preference, v2(2, N=23)=9.74, P=0.008.
3.1.3. Symptom improvement and remission rates
An ANOVA on SIGH-SAD scores revealed a
significant occasion main effect, F(1,20)=74.13,
P<0.001, g2=0.788 (see Fig. 1). Similarly, with
BDI-II scores as the dependent measure, an
ANOVA revealed a significant occasion main effect,
F(1,19)1=82.72, P<0.001, g2=0.813 (see Fig. 2). On
both measures, participants, in general, improved
over the course of all three treatments, group-
occasion, ns. The same pattern of results was
obtained when the HAM-D and atypical subscale
scores were analyzed separately.
Based on SIGH-SAD criteria, the CBT+LT dem-
onstrated the highest remission rate. Using BDI-II
criteria, a greater percentage of CBT-treated partici-
pants were classified as remitted than those treated
with CBT+LT or LT. However, remission results did
not reach significance (see Table 1).
3.2. 1-Year follow-up results
3.2.1. Attrition
Of this sample, 21 (seven CBT, eight LT, six
CBT+LT) attended the 1-year follow-up evaluation
during January or February 2002. The remaining two
participants (one LT, one CBT+LT, both female) were
contacted, but declined to participate.
3.2.2. Symptom severity, relapse rates, and remission
rates
Follow-up SIGH-SAD scores differed across the
treatment groups, F(2,18)=4.39, P=0.028, g2=0.328,
indicating that CBT+LT had lower SIGH-SAD scores
than LT, P<0.05. CBT demonstrated a trend towards
lower SIGH-SAD scores than LT, P<0.08 (see Fig. 1).
HAM-D and atypical subscale score results demon-
strated the same pattern. Follow-up BDI-II scores also
differed by group, F(2,18)=6.10, P=0.009, g2=0.404,
1 Note: one CBT+LT participant failed to complete the BDI-II
at post-treatment.
Fig. 2. BDI-II scores across occasions.
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whereby CBT- and CBT+LT-treated participants had
lower BDI-II scores than those treated with LT,
Ps<0.05 (see Fig. 2).
In terms of relapse prevention, no CBT-treated
participant, with or without light, met SIGH-SAD
criteria for a relapse at the follow-up visit relative to
62.5% of light-treated participants who relapsed.
These proportions were significantly different (see
Table 2). At follow-up, CBT+LT had the highest
remission rate using both SIGH-SAD and BDI-II
criteria, but the difference was ns (see Table 1).
3.2.3. SAD-management behaviors
Because significant differences between treatments
were revealed at the follow-up, between-group differ-
ences in SAD-management behaviors were examined
to explore potential reasons behind these discrepan-
cies (see Table 3). Given the small sample, group
main effects with medium effect sizes (z0.25; Cohen,
1988) were considered meaningful. Group main
effects were revealed for frequency of positive think-
ing, socializing frequency, perceived helpfulness of
socializing, and frequency of going South. These
group main effects were followed with Tukey’s pair-
wise comparisons with P set at 0.05. CBT +LT
participants scored higher on all these factors relative
to LT participants, and the CBT group reported more
frequent socializing than the LT group. Two partic-
ipants (both treated with CBT+LT) reported contin-
ued use of light at follow-up, but only one reported an
adequate dose. Five participants (two CBT, two LT,
one CBT+LT) reported some involvement in psycho-
therapy, and six (three LT, two CBT+LT, one CBT)
reported use of antidepressant medications, primarily
selective serotonin reuptake inhibitors (SSRIs).
4. Discussion
To our knowledge, this is the first published study
to apply a cognitive-behavioral intervention to SAD.
These preliminary findings suggest promise for the
utility of cognitive-behavioral therapy (CBT) in the
treatment of SAD, particularly as an adjunct to light
therapy. CBT alone, light therapy alone, and the
combination of CBT and light all significantly im-
proved symptoms across the 6-week trial. This pattern
of results was obtained across two different measures
of depressive symptoms—the Beck Depression In-
ventory–Second Edition (BDI-II) and Structured In-
terview Guide for the Hamilton Depression Rating
Scale–SAD Version (SIGH-SAD), thereby increasing
the likelihood these results are not specific to a
particular measure.
At post-treatment, remission rates varied depend-
ing on outcome measure, although results did not
reach statistical significance. When SIGH-SAD re-
mission criteria were used, the role of CBT as an
adjunct to light therapy appeared especially encour-
aging. In a possible synergistic effect, these two
treatments together demonstrated the highest remis-
sion rate following treatment. In contrast, when re-
mission was defined using BDI-II scores, CBT alone
Table 1
Remission rates at post-treatment and at 1-year follow-up
SIGH-SAD



















a v2(2, N = 23) = 1.17, ns.
b v2(2, N = 21) = 3.27, ns.
c v2(2, N = 22) = 2.29, ns.
d v2(2, N = 21) = 2.77, ns.
Table 2
Relapse rates at 1-year follow-up




v2(2, N = 21) = 10.66, P= 0.005.
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actually had a higher remission rate than the combined
treatment or light therapy. This discrepancy in results
was largely unexpected, but may be explained by
differences between these measures. The SIGH-SAD
places greater emphasis on the somatic symptoms of
depression, especially the reverse vegetative symp-
toms, whereas the BDI-II encompasses the cognitive,
behavioral, and affective features of depression.
Importantly, these preliminary findings suggest
that CBT, alone or in combination with light therapy,
may improve long-term outcome regarding symptom
severity, relapse, and remission rates. In general, CBT-
treated participants appeared to maintain or improve
upon their initial treatment gains into the subsequent
winter season. Most impressively, no CBT-treated
participant, with or without adjunct light treatment,
experienced a full relapse to a SAD episode at the 1-
year follow-up compared to over 60% of participants
treated with light alone. Despite the small sample,
other significant differences between treatments
emerged 1 year after treatment termination. Both the
CBT+LT and CBT groups had significantly lower
BDI-II scores than the LT group; and CBT+LT
participants had significantly lower SIGH-SAD scores
than LT participants. In addition, CBT+LT had the
highest remission rate on both outcome measures,
although this difference did not reach significance.
A few potential explanatory factors emerged behind
these differences. The superiority of CBT+LTover LT
1-year later may be attributed to their more frequent
Table 3
SAD-management behaviors at 1-year follow-up
Specific strategies CBT LT CBT+LT F(2,18) P g2 Post hocs
Consistent with CBT approach
Thinking positively
Frequency, mean (S.E.M.) 1.71 (0.29) 1.38 (0.18) 2.17 (0.14) 3.15 0.067 0.259 CBT+LT > LT
Helpfulness, mean (S.E.M.) 2.71 (0.18) 2.25 (0.31) 2.67 (0.33) 0.86 0.441 0.087 –
Increasing my activity level
Frequency 1.86 (0.26) 1.50 (0.38) 2.17 (0.31) 1.02 0.381 0.102 –
Helpfulness 2.43 (0.37) 2.50 (0.19) 2.83 (0.17) 0.63 0.546 0.065 –
Socializing with other people
Frequency 1.57 (0.53) 0.88 (0.23) 2.00 (0.43) 3.87 0.040 0.301 CBT, CBT+LT > LT
Helpfulness 2.14 (0.34) 1.63 (0.26) 2.83 (0.41) 4.71 0.023 0.344 CBT+LT > LT
Being more aware of my SAD symptoms
Frequency 2.00 (0.31) 2.00 (0.33) 2.50 (0.34) 0.71 0.503 0.074 –
Helpfulness 2.00 (0.49) 1.75 (0.41) 2.67 (0.21) 1.29 0.301 0.125 –
Exercising
Frequency 1.43 (0.37) 1.50 (0.33) 1.67 (0.49) 0.09 0.914 0.010 –
Helpfulness 2.25 (0.26) 2.63 (0.18) 2.50 (0.22) 1.32 0.293 0.127 –
Consistent with LT approach:
Using a light box
Frequency – – 0.83 (0.48) 2.11 0.150 0.190 –
Helpfulness 1.43 (0.53) 1.75 (0.25) 1.83 (0.22) 0.28 0.761 0.030 –
Going outside
Frequency 2.00 (0.31) 1.88 (0.30) 2.33 (0.33) 0.55 0.587 0.057 –
Helpfulness 2.57 (0.20) 2.75 (0.16) 3.00 (0.00) 1.67 0.217 0.156 –
Making my home brighter
Frequency 1.14 (0.40) 1.25 (0.31) 2.17 (0.31) 2.40 0.119 0.210 –
Helpfulness 2.14 (0.34) 1.75 (0.49) 2.83 (0.17) 1.90 0.179 0.174 –
Going South on a trip/vacation
Frequency 0.71 (0.42) 0.38 (0.52) 1.67 (0.42) 3.65 0.047 0.288 CBT+LT > LT
Helpfulness 1.86 (0.51) 2.38 (0.74) 3.00 (0.00) 2.58 0.104 0.223 –
Keeping a regular sleep schedule
Frequency 2.33 (0.33) 1.50 (0.33) 2.00 (0.37) 1.53 0.236 0.156 –
Helpfulness 2.86 (0.14) 2.13 (0.40) 2.67 (0.21) 1.77 0.199 0.164 –
Frequency of items was rated on a Likert scale: 0=almost never, 1=sometimes, 2=often, 3=almost always. Helpfulness was rated on a Likert
scale: 0=completely unhelpful, 1=slightly helpful, 2=moderately helpful, 3=very helpful.
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social activities, positive thinking, and trips South.
CBT participants also reported more frequent sociali-
zation than LT participants at follow-up. These find-
ings are consistent with studies in the nonseasonal
depression literature documenting the long-term dura-
bility of cognitive-behavioral therapy (Blackburn et al.,
1986; Fava et al., 1998; Paykel et al., 1999). Because
light therapy requires a considerable time commitment
from the patient and is associated with long-term
noncompliance (Schwartz et al., 1996), CBT may be
a more cost-effective way to treat SAD in the long run.
Our findings are consistent with recent models that
attempt to integrate physiological and psychological
vulnerability factors in explaining SAD onset and
maintenance (Young, 1999). These results should
not be interpreted as inconsistent with biological
conceptualizations of SAD because, in prior studies,
cognitive-behavioral approaches have been applicable
to disorders with known biological underpinnings. For
example, these results parallel the nonseasonal de-
pression literature where CBT has demonstrated effi-
cacy for even endogenous major depressive disorder
(e.g. Thase et al., 1991).
Although promising, our results should be viewed
as preliminary and are limited by the small sample
size and lack of a control group. We cannot rule out
the possibility that apparent treatment effects in all
groups were due to the passage of time or regression
to the mean. However, we doubt that to be the case
because post-treatment remission rates for our best
available treatment ‘control’ group (i.e. light therapy)
match those from a large-scale meta-analysis, and the
superiority of light therapy over no- or delayed-
treatment and placebo light controls has been estab-
lished (Terman et al., 1989).
With the optimal time of day for bright light
administration remaining controversial in the field,
our dual morning–evening administration of light
therapy represents another possible weakness in our
design. Terman et al.’s (1989) meta-analysis concluded
that morning light therapy was superior to evening or
mid-day light and that the dual exposure of morning
plus evening light did not confer any significant
benefits over morning alone. Two recent trials suggest
that morning light may be more effective than evening
light, but did not include a morning plus evening light
therapy condition (Terman et al., 2001, 1998). One
recent study that included a split-dose condition found
that timing light administration in morning only, even-
ing only, or split between morning and evening pro-
duced similar antidepressant effects at the end of the 5-
week trial (Ruhrmann et al., 1998). Future comparisons
of CBT and light therapy for SAD should consider
using a morning only dose of light therapy.
In conclusion, the nearly half of SAD sufferers
who do not remit with light alone may possibly
benefit from CBT as a supplementary or alternative
treatment, particularly for maximizing long-term out-
come and preventing relapse. Because these early
results warrant further exploration, we currently have
a larger, sufficiently powered study underway. Our
new trial will seek to replicate this method with the
addition of a minimal-contact/delayed light therapy
control group (i.e. light treatment following a 6-week
waiting period) to help in ruling out alternate explan-
ations for any observed treatment effects. In making
this shift from pilot study to full clinical trial, we will
determine with greater certainty whether CBT has a
role in the treatment of SAD.
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